{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-2.5-pro",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "type": {
          "id": "3b429768-9cd4-40ae-9d6d-6bc8f117b913",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "bf2be5b7-abe2-4fe3-a477-de1888cd8173",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "type": {
          "id": "13c67f7c-8e38-4b45-8689-f791f7b2871c",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "27e7f804-ca10-4114-8b58-eb4a9e60e3fd",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular glucagon (IMG) used as an active comparator.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human regular insulin",
        "type": {
          "id": "c37b3832-9c79-4c8c-bbe1-836ae920d314",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "6ed9e463-933a-4af7-b113-8d0eb3f8bb69",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered via IV infusion to induce hypoglycemia for the study procedure.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "IV glucose",
        "type": {
          "id": "1459ea14-255c-48ef-8a9d-f64071b7b782",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "2bff01dc-a913-495a-a2b3-66c00ca4e581",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if a patient's bedside plasma glucose concentration remains low after glucagon administration or if severe hypoglycemia symptoms occur.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018",
        "administrableDoseForm": {
          "id": "2645ae2c-9317-4850-a718-df3aa5fa4e81",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "79b4f91a-0d4f-4b94-9bec-3ab33b6dc94c",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "2731dfeb-f2d8-47c6-b651-d032a9e045e8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "3 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Lilly"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "administrableDoseForm": {
          "id": "1eaa42a2-7bf4-45ba-a544-a793c3e571eb",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "85245e88-fb38-44bc-b0c4-5a7b58e4bf6a",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "60df7fc6-19a9-46ed-8a33-8b11e339595e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "id": "prod_3",
        "name": "Human regular insulin",
        "administrableDoseForm": {
          "id": "4cda82ac-7b47-4a04-b72a-4a079d21def2",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "7916af23-dd0d-4283-9209-aa736f46560a",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "0bb2dab7-bbb2-4d40-88c0-62141f27d645",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 U/mL diluted to 0.3 U/mL",
        "substanceIds": [
          "sub_3"
        ]
      },
      {
        "id": "prod_4",
        "name": "IV glucose",
        "administrableDoseForm": {
          "id": "cbf763c5-77aa-45ee-bfee-df06759d6c2a",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "9d6d8be5-674c-42ca-a6d4-ecc5d7d8c742",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "76d17854-6075-428c-a4e4-915f23a6d0e8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018 3 mg single dose",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "single dose per period",
        "route": {
          "code": "Intranasal",
          "codeSystem": "USDM",
          "decode": "Intranasal"
        },
        "duration": "Single administration"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen 1 mg single dose",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "single dose per period",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration"
      },
      {
        "id": "admin_3",
        "name": "Human regular insulin infusion",
        "instanceType": "Administration",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "doseFrequency": "once per period",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until bedside plasma glucose level is <60 mg/dL, for a maximum of 4 hours."
      },
      {
        "id": "admin_4",
        "name": "IV glucose rescue",
        "instanceType": "Administration",
        "dose": "As deemed clinically necessary",
        "doseFrequency": "As needed",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "As needed"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "glucagon",
        "instanceType": "Substance",
        "description": "A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "id": "sub_2",
        "name": "human regular insulin",
        "instanceType": "Substance",
        "description": "Active substance used to induce hypoglycemia."
      },
      {
        "id": "sub_3",
        "name": "glucose",
        "instanceType": "Substance",
        "description": "Active substance in rescue medication for insufficient response to glucagon."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal delivery device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Lilly"
      }
    ],
    "summary": {
      "interventionCount": 4,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia."
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular glucagon (IMG) used as an active comparator."
      },
      {
        "name": "Human regular insulin",
        "role": "Concomitant Medication",
        "description": "Administered via IV infusion to induce hypoglycemia for the study procedure."
      },
      {
        "name": "IV glucose",
        "role": "Rescue Medication",
        "description": "Administered if a patient's bedside plasma glucose concentration remains low after glucagon administration or if severe hypoglycemia symptoms occur."
      }
    ],
    "products": [
      {
        "name": "LY900018",
        "doseForm": "Nasal powder",
        "strength": "3 mg",
        "manufacturer": "Lilly"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Powder for injection",
        "strength": "1 mg",
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "name": "Human regular insulin",
        "doseForm": "Solution for infusion",
        "strength": "100 U/mL diluted to 0.3 U/mL",
        "manufacturer": null
      },
      {
        "name": "IV glucose",
        "doseForm": "Solution for infusion",
        "strength": null,
        "manufacturer": null
      }
    ],
    "substances": [
      {
        "name": "glucagon",
        "description": "A synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "name": "human regular insulin",
        "description": "Active substance used to induce hypoglycemia."
      },
      {
        "name": "glucose",
        "description": "Active substance in rescue medication for insufficient response to glucagon."
      }
    ],
    "administrations": [
      {
        "name": "LY900018 3 mg single dose",
        "dose": "3 mg",
        "frequency": "single dose per period",
        "route": "Intranasal",
        "duration": "Single administration"
      },
      {
        "name": "GlucaGen 1 mg single dose",
        "dose": "1 mg",
        "frequency": "single dose per period",
        "route": "Intramuscular",
        "duration": "Single administration"
      },
      {
        "name": "Human regular insulin infusion",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "frequency": "once per period",
        "route": "Intravenous",
        "duration": "Until bedside plasma glucose level is <60 mg/dL, for a maximum of 4 hours."
      },
      {
        "name": "IV glucose rescue",
        "dose": "As deemed clinically necessary",
        "frequency": "As needed",
        "route": "Intravenous",
        "duration": "As needed"
      }
    ],
    "devices": [
      {
        "name": "Nasal delivery device",
        "manufacturer": "Lilly",
        "purpose": "A single-use, nasal dosing device included as part of the LY900018 investigational drug product to deliver the contained drug constituent."
      }
    ]
  }
}